GEODE CAPITAL MANAGEMENT, LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in CATX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,384,074
+$1,015,852 QoQ
Shares Held
2,458,673
+39.1% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 130 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $16,628,576,724 across 127 Medical Devices names. CATX ranks #58 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
39,219,337 | $3,558,762,638 | |
| 2 | SYK |
Stryker Corp
|
7,819,802 | $2,461,986,461 | |
| 3 | MDT |
Medtronic plc
|
30,192,015 | $2,361,921,333 | |
| 4 | BSX |
Boston Scientific Corp
|
33,440,102 | $1,427,223,552 | |
| 5 | EW |
Edwards Lifesciences Corp
|
15,437,251 | $1,396,453,724 | |
| 6 | DXCM |
Dexcom Inc
|
12,426,515 | $836,925,784 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
12,871,800 | $823,923,917 | |
| 8 | STE |
STERIS plc
|
2,615,842 | $550,817,849 |
All Filings in CATX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,384,074 | 2,458,673 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $7,368,222 | 1,766,960 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,889,935 | 1,414,522 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,913,429 | 1,432,487 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,756,879 | 1,382,814 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,543,063 | 1,193,927 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,724,094 | 1,167,428 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $15,542,122 | 1,164,204 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $10,314,462 | 1,034,550 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,207,055 | 4,375,677 | Shares | Defined | 2024-05-13 | |
| 2023-09-30 | $679,495 | 2,516,649 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,641,432 | 2,449,899 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,193,059 | 1,864,156 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $285,388 | 1,141,555 | Shares | Defined | 2023-02-13 | |
| 2022-06-30 | $350,642 | 1,131,105 | Shares | Defined | 2022-08-12 | |
| 2021-09-30 | $705,014 | 1,119,070 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $895,256 | 1,119,070 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,072,807 | 984,227 | Shares | Defined | 2021-05-12 | |
| 2020-09-30 | $187,766 | 323,736 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $181,292 | 323,736 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $171,580 | 323,736 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||